di Reumatologia, Società Italiana, trans. 2025. “CO:01:1 | Efficacy and Safety of Rituximab across the Four Phenotypes of IgG4-Related Disease: A European Multi-Center Cohort Study of 115 Patients: Marco Lanzillotta1, Jens Vikse2, Elisabetta Goni3, Veronica Batani1, Jasmin Mahajne1, Lorenzo Dagna1, Emanuel Della Torre1. | 1Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; 2Department of Rheumatology, Stavanger University Hospital, Norway; 3Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.1961.